COVID-19, SARS-CoV-2 Vaccination, and Arthritis

John Murphy, CEO The COVID-19 Long-haul Foundation Abstract The COVID-19 pandemic has revealed an extensive rheumatologic phenotype extending well beyond the respiratory tract. SARS-CoV-2 infection may be followed by arthralgia, […]

Nail Manifestations of SARS-CoV-2 Infection (COVID-19): Etiology, Pathophysiology, Histopathology, Clinical Features, and Outcomes

John Murphy, CEO, The COVID-19 Long Haul Foundation Abstract SARS-CoV-2 infection has been associated with delayed nail abnormalities including Beau’s lines, onychomadesis, transverse leukonychia, and chromonychia (“COVID nails”). These manifestations […]

COVID Fatigue: Etiology, Genomics, Physiology, Pathology, Neurobiology, Sleep Disturbance, Treatment, and Prognosis

John Murphy, CEO COVID-19 Long-haul Foundation Abstract Fatigue is the most prevalent and disabling symptom among survivors of SARS‑CoV‑2 infection, persisting in a substantial proportion of patients months to years […]

Dimensional Distribution of mRNA Vaccine-Derived Spike Proteins: Etiology, Physiology, and Pathological Risk Profiles

John Murphy, MD CEO & President, COVID-19 Long-haul Foundation Abstract Messenger RNA (mRNA) vaccines have revolutionized infectious disease prevention, yet their biodistribution and systemic effects remain incompletely characterized. This article […]

Endothelial Dysfunction and Spike Protein Persistence in Long COVID: Mechanisms, Vulnerabilities, and Clinical Evidence

Author: John Murphy, President, COVID-19 Long-haul Foundation Abstract Long COVID, or post-acute sequelae of SARS-CoV-2 infection (PASC), is characterized by persistent symptoms affecting multiple organ systems. Among its most compelling […]